GPT and metabolic dysfunction-associated steatotic liver disease: Increased serum ALT levels (even levels at the high end of normal) are associated with markers of CVD59, and they may therefore have prognostic value in assessing NAFLD patients, in whom they may potentially indicate an increased risk of CVD[62].